Phathom Pharmaceuticals, Inc. ·
PHAT 8-K 2026-09-29
Phathom Pharmaceuticals, Inc. (PHAT) 8-K dated 2026-09-29 — accession 0001193125-26-407696.
Phathom Pharmaceuticals, Inc. (PHAT) is a biotechnology company listed on US.
Phathom Pharmaceuticals, Inc. filed a 8-K on 2026-09-29. Accession 0001193125-26-407696.
This 8-K covers: Other events (Item 8.01). SEC EDGAR holds the official filing and its exhibits.
Latest reported PHAT revenue for 2025-12-31 was $175.1M. Net income was -$221.2M. Revenue was up 216.9% from 2024-12-31 to 2025-12-31. PHAT currently screens at market cap $622.7M.
Not investment advice. The PHAT SEC hub lists recent forms. The stock page is the research view.